國家衛生研究院 NHRI:Item 3990099045/8800
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 912266      線上人數 : 1159
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於NHRI管理 到手機版
    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/8800


    題名: Chemokine IP-10 is correlated with cardiac responses and status of infection with HIV and HCV in methadone maintenance patients
    作者: Liu, SW;Liu, YL;Hwang, LL;Wang, SC;Kuo, HW;Wu, SL;Dai, YWE;Liu, SC;Ho, IK;Chen, ACH;Hsiao, CF;Tsou, HH
    貢獻者: Center for Neuropsychiatric Research;Division of Biostatistics and Bioinformatics;Division of Clinical Trial Statistics
    摘要: To the Editor,Methadone is a synthetic opioid usually used as a maintenance therapy for heroin dependence [1]. It has been reported that the infection rates with human immunodeficiency virus (HIV) and/or hepatitis C virus (HCV) were higher in patients undergoing methadone maintenance treatment (MMT) [2]. However, the influence of co-infection with HIV and HCV on the treatment responses to methadone has yet to be studied. A higher plasma level of chemokine interferon gamma-inducible protein 10 (IP-10, also called chemokine (C-X-C motif) ligand 10, CXCL 10) has been reported in patients infected with both HIV and HCV than those infected with only single virus [3]. Increased expression of IP-10, CXCR3 receptors in the CD8(+) lymphocytes has also been reported in patients co-infected with HIV and HCV [4]. Furthermore, IP-10 has been suggested as a biomarker for predicting the HCV treatment outcome for patients infected with both HIV and HCV [5]. However, the influence of chemokines/cytokines on the treatment responses to methadone and HIV/HCV infection remains unclear.We recruited 366 Han Chinese subjects with heroin dependence undergoing MMT in outpatient settings in Taiwan to investigate the impact of HIV/HCV infection on the levels of chemokines or cytokines and the treatment responses to methadone. 331 patients were screened for HCV, and 329 for HIV antibody. Detailed demography of subjects is shown in Table 1. Only one patient was tested positive for HIV-antibody but not HCV, hence it was excluded from further analysis because of the small sample size. A higher initial methadone dose (P = 0.038), higher plasma concentrations of (R,S)-methadone (P = 0.038) and R-methadone (P = 0.028), lower ratio of S-EDDP/methadone dose (P = 0.043), higher levels of AST (P = 0.048) and ALT (P = 0.046), and a longer addiction duration (P < 0.0001) were found in the HIV(+)/HCV(+) or HCV(+) patients than the HIV(−)/HCV(−) patients ( Table 1). The results of urine morphine test, which was used as a surrogate indicator for the effectiveness of opioid dependence treatment [6], were not statistically different among subjects grouped by their status of HIV and/or HCV infection.
    日期: 2015-09-01
    關聯: International Journal of Cardiology. 2015 Sep 1;194:36-38.
    Link to: http://dx.doi.org/10.1016/j.ijcard.2015.05.055
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0167-5273&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000356053900008
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84930946029
    顯示於類別:[王聲昌] 期刊論文
    [劉玉麗] 期刊論文
    [鄒小蕙] 期刊論文
    [蕭金福] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    NBS2015051301.pdf229KbAdobe PDF565檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋